Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer

Ronald C. Bruntz, Craig W. Lindsley, H. Alex Brown

Research output: Contribution to journalReview articlepeer-review

238 Scopus citations

Abstract

Phospholipase D is a ubiquitous class of enzymes that generates phosphatidic acid as an intracellular signaling species. The phospholipase D superfamily plays a central role in a variety of functions in prokaryotes, viruses, yeast, fungi, plants, and eukaryotic species. In mammalian cells, the pathways modulating catalytic activity involve a variety of cellular signaling components, including G protein-coupled receptors, receptor tyrosine kinases, polyphosphatidylinositol lipids, Ras/Rho/ADP-ribosylation factor GTPases, and conventional isoforms of protein kinase C, among others. Recent findings have shown that phosphatidic acid generated by phospholipase D plays roles in numerous essential cellular functions, such as vesicular trafficking, exocytosis, autophagy, regulation of cellular metabolism, and tumorigenesis. Many of these cellular events are modulated by the actions of phosphatidic acid, and identification of two targets (mammalian target of rapamycin and Akt kinase) has especially highlighted a role for phospholipase D in the regulation of cellular metabolism. Phospholipase D is a regulator of intercellular signaling and metabolic pathways, particularly in cells that are under stress conditions. This review provides a comprehensive overview of the regulation of phospholipase D activity and its modulation of cellular signaling pathways and functions.

Original languageEnglish
Pages (from-to)1033-1079
Number of pages47
JournalPharmacological Reviews
Volume66
Issue number4
DOIs
StatePublished - Oct 1 2014

Bibliographical note

Publisher Copyright:
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Funding

FundersFunder number
Department of Pharmacology (R.C.B., C.W.L., H.A.B.) and Vanderbilt Center for Neuroscience Drug Discovery (C.W.L.), Vanderbilt University Medical Center; Department of Chemistry, Vanderbilt Institute of Chemical Biology (C.W.L., H.A.B.); Vanderbilt Specialized Chemistry for Accelerated Probe Development (C.W.L.); and Department of Biochemistry, Vanderbilt-Ingram Cancer Center (H.A.B.), Vanderbilt UniversityT32 GM007628, P01-ES013125, U54-MH084659
National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical SciencesT32GM007628

    ASJC Scopus subject areas

    • Molecular Medicine
    • Pharmacology

    Fingerprint

    Dive into the research topics of 'Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer'. Together they form a unique fingerprint.

    Cite this